STRATA Skin Sciences Full Year 2023 Earnings: Misses Expectations

STRATA Skin Sciences, Inc. -0.63%

STRATA Skin Sciences, Inc.




STRATA Skin Sciences (NASDAQ:SSKN) Full Year 2023 Results

Key Financial Results

  • Revenue: US$33.4m (down 7.8% from FY 2022).
  • Net loss: US$10.8m (loss widened by 95% from FY 2022).
  • US$0.31 loss per share (further deteriorated from US$0.16 loss in FY 2022).
NasdaqCM:SSKN Earnings and Revenue Growth March 29th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

STRATA Skin Sciences Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 3.8%. Earnings per share (EPS) also missed analyst estimates by 44%.

Looking ahead, revenue is forecast to grow 2.1% p.a. on average during the next 2 years, compared to a 7.9% growth forecast for the Medical Equipment industry in the US.

Performance of the American Medical Equipment industry.

The company's shares are down 22% from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with STRATA Skin Sciences, and understanding these should be part of your investment process.

Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via